We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Consumer Discretionary 15.2%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QLYS icon
201
Qualys
QLYS
$5.51B
$2.85M 0.07%
111,105
+14,580
+15% +$332K
CYBX
202
DELISTED
CYBERONICS INC
CYBX
$2.84M 0.07%
45,425
+75
+0.2% +$4.57K
WDAY icon
203
Workday
WDAY
$36.4B
$2.72M 0.06%
30,235
-45
-0.1% -$3.54K
KKD
204
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$2.66M 0.06%
166,685
+10,035
+6% +$174K
ECHO
205
DELISTED
Echo Global Logistics, Inc.
ECHO
$2.66M 0.06%
138,875
-475
-0.3% -$8.71K
THOR
206
DELISTED
THORATEC CORPORATION
THOR
$2.64M 0.06%
75,670
-95
-0.1% -$3.17K
GBCI icon
207
Glacier Bancorp
GBCI
$6.81B
$2.44M 0.06%
85,805
+215
+0.3% +$5.79K
GNC
208
DELISTED
GNC Holdings, Inc.
GNC
$2.41M 0.06%
70,785
-4,125
-6% -$164K
XPO icon
209
XPO
XPO
$24.7B
$2.31M 0.05%
+233,639
New +$2.13M
JACK icon
210
Jack in the Box
JACK
$280M
$2.27M 0.05%
37,875
+20
+0.1% +$1.15K
EAT icon
211
Brinker International
EAT
$8.36B
$2.21M 0.05%
45,400
-15,075
-25% -$756K
PODD icon
212
Insulet
PODD
$11.6B
$2.18M 0.05%
54,985
+25,415
+86% +$977K
PANW icon
213
Palo Alto Networks
PANW
$284B
$2.12M 0.05%
151,530
+90
+0.1% +$1.05K
TECH icon
214
Bio-Techne
TECH
$11.2B
$1.87M 0.04%
80,700
-100
-0.1% -$2.21K
VSI
215
DELISTED
Vitamin Shoppe Inc.
VSI
$1.85M 0.04%
42,925
-200
-0.5% -$8.99K
SCOR icon
216
Comscore
SCOR
$112M
$1.77M 0.04%
2,500
– –
WDR
217
DELISTED
Waddell & Reed Financial, Inc.
WDR
$1.58M 0.04%
25,220
-10,195
-29% -$660K
QCOM icon
218
Qualcomm
QCOM
$180B
$1.19M 0.03%
15,070
– –
EMC
219
DELISTED
EMC CORPORATION
EMC
$932K 0.02%
35,400
– –
DXCM icon
220
DexCom
DXCM
$29.2B
$892K 0.02%
90,000
– –
TRV icon
221
Travelers Companies
TRV
$78.4B
$760K 0.02%
8,085
-500
-6% -$45.6K
CNA icon
222
CNA Financial
CNA
$14.3B
$723K 0.02%
17,900
– –
PEP icon
223
PepsiCo
PEP
$185B
$670K 0.02%
7,500
– –
SYK icon
224
Stryker
SYK
$122B
$657K 0.02%
7,800
-126,910
-94% -$10.4M
COR icon
225
Cencora
COR
$59.1B
$552K 0.01%
7,600
– –
7 8
9
10 11

Similar funds

VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.